it referred to the fact that the merck's proposed exclusion on manufacturing documents, as expressed in order 4 of its notice of motion, expressly referred to "documents relating to the adaptation of the processes claimed".
i apprehend that this conclusion may resolve issues concerning electronic discovery and also issues concerning the manufacturing process.
alphapharm's pleading on this issue as particularised, is that "the alleged invention as claimed in each of claims 1, 2, 3, 4, 6, 7, 8, 9, 10, 11, 12, 18 and dependent claim 13, 14, 15 and 29 is not a patentable invention within the meaning of s 18(1)(c) of the act in that it is not useful.